Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation

Tag: Covid-19

February 4, 2021 Drug delivery / Pharma applications

Thapsigargin repurposing for COVID-19

Whilst COVID-19 vaccines are being rolled out for mass vaccination, the modest number of antivirals in use or development for

Continue reading

January 28, 2021 Pharma applications

A polypeptide, Plitidepsin has potent preclinical efficacy against SARS-CoV-2

The science reported that the drug plitidepsin (aplidin), which has limited clinical approval, possesses antiviral activity (IC90 = 0.88 nM) 27.5-fold

Continue reading

December 18, 2020 Drug delivery / Pharma applications

Novel drug for oral treatment against Covid-19

Nature Microbiology reported on an orally efficacious ribonucleoside analogue inhibitor of influenza viruses, MK-4482/EIDD-2801, that was repurposed for use against

Continue reading

December 7, 2020 Non-pharma applications / Pharma applications

Global Alpha-Cyclodextrin Market Outlook And Regional Analysis with Impact Analysis of COVID-19 (2021-2030)

APNEWS reported: This exhaustive Alpha-Cyclodextrin market report provides a full holistic analysis [2012-2019], market size and time frame [2021-2030], emerging

Continue reading

November 24, 2020 Drug delivery / Pharma applications

Utility of aspirin in hospitalized COVID-19 patients

A recent paper published in Anesthesia & Analgesia Journal evaluated the possible benefits of using aspirin in hospitalized COVID-19 patients

Continue reading

November 19, 2020 CD as API / Pharma applications

Alpha-CD-containing oral spray to inhibit the SARS-CoV-2 endocytosis

Italian researchers developed an oral spray (Endovir Stop) containing alpha-cyclodextrin (0.2%) and hydroxytyrosol (3.8%) for the improvement of the defenses

Continue reading

November 11, 2020 Drug delivery / Non-pharma applications / Other industrial use / Pharma applications / Uncategorized

FIRST EXPERIMENTS IN SPACE FOR COVID-19 DRUG RESEARCH

The COVID-19 pandemic has generated new and urgent challenges in drug discovery and development. Veklury®, a remdesivir-based medicament invented by

Continue reading

November 10, 2020 Pharma applications

Pfizer and BioNTech announced vaccine candidate against covid-19 achieved success in first interim analysis from Phase 3 study

Pfizer’s Early Data Shows Vaccine Is More Than 90% Effective Pfizer and BioNTech announced on 09 October their mRNA-based vaccine

Continue reading

October 29, 2020 Drug delivery / Pharma applications

Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients

Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s

Continue reading

October 24, 2020 Drug delivery / Pharma applications

U.S. FDA Approves Gilead’s Antiviral Veklury® (remdesivir) for Treatment of COVID-19

— Veklury Is First and Only FDA-Approved Treatment for COVID-19 in the United States — — Veklury Shortened Time to

Continue reading

Posts pagination

«Previous Posts 1 … 5 6 7 8 9 … 14 Next Posts»

Recent Posts

  • Can a Cyclodextrin Really Stop Body Odor by Quorum Quenching?
  • Disruption of Lipid Sorting and Endosomal Transport in Cyclodextrin-mediated Cytotoxicity
  • 4th International Aquatic Biotechnology Symposium
  • Cyclodextrin metal-organic framework engineered titanium surface: Targeted modulation of foam cell lipid homeostasis and inflammatory resolution
  • Reviewing Cyclodextrin-Grafted Polysaccharides as Sustainable Platforms for Biomedical and Environmental Applications

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

  • LinkedIn
  • X
  • Facebook

Categories

  • Agriculture (27)
  • Analysis (73)
  • CD as API (352)
  • CD derivatives (428)
  • Cosmetics and toilettry (53)
  • Diagnosis (13)
  • Drug delivery (806)
  • E-ducation (63)
  • Environmental (143)
  • Events (237)
  • Food (230)
  • Gene delivery (22)
  • Household products (5)
  • Household products (1)
  • In Hungarian (4)
  • Life sciences (44)
  • Non-pharma applications (411)
  • Other industrial use (111)
  • Pharma applications (1,206)
  • Supramolecular systems (44)
  • Uncategorized (164)

Top Posts

  • Can a Cyclodextrin Really Stop Body Odor by Quorum Quenching?
  • Disruption of Lipid Sorting and Endosomal Transport in Cyclodextrin-mediated Cytotoxicity
  • FDA Grants Approval to HPBCD-Enhanced Biologic: A 'Super-Originator' Formulation
  • The monograph of SBECD is official in the European Pharmacopeia
  • Lanosterol eye drops for cataract treatment
  • Cyclodextrins as Multi-Functional Ingredients in Dentistry
  • Bridion® injection now approved for patients of all ages
  • New clinical trial with cyclodextrins on hernia treatment
  • Method for HPBCD analysis in pharmaceutical formulations
  • Cyclodextrin based Nanosponges increased the anticancer and antimicrobial properties of the natural peptide Nisin

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 4,476 other subscribers
Loading Comments...